Forum for Science, Industry and Business
Sponsored by:     Siemens  n-tv 
Search our Site:

Topic (optional):

 

Home Reports Health and Medicine Content

Antidepressant drugs can get depression better, but cannot keep well

next article
21.12.2006

In a paper published in the current issue of Expert Review of Neurotherapeutics, Giovanni A. Fava, Seung Park and Nicoletta Sonino (University of Bologna and SUNYAB at Buffalo) examine the evidence on the role of antidepressant drugs in preventing a depressive relapse. The news is rather depressing. But the role of psychotherapy much more encouraging.

 

Approximately 8 of 10 people experiencing a major depressive episode will have one or more further episodes during their lifetime, a recurrent major depressive disorder. Prolongation or lifelong pharmacotherapy has emerged as the main therapeutic tool for preventing relapse in depression. However, outcome after discontinuation of antidepressants does not seem to be affected by the duration of their administration. Loss of clinical effects, despite adequate compliance, has also emerged as a vexing clinical problem.


Use of intermittent pharmacotherapy with follow-up visits is another therapeutic option that would leave patients with periods free of drugs and side effects, in consideration of the fact that a high proportion of patients would discontinue the antidepressant anyway. However, the problems of resistance (the fact that a drug treatment may be associated with a diminished chance of response in those patients who successfully responded to it, but discontinued it) and of discontinuation syndromes are a substantial disadvantage of this therapeutic option.

In recent years, several controlled trials have suggested that a sequential use of pharmacotherapy in the treatment of the acute episode and psychotherapy in its residual phase may improve long-term outcome. Patients, however, should be motivated for psychotherapy and skilled therapists should be available.
It is important to discuss with the patient the various therapeutic options and to adapt strategies to the specific needs of patients.

Giovanni Andrea Fava | Source: alphagalileo
Further information: www.unibo.it

next article

More articles from Health and Medicine:

nachricht Polyphenols and polyunsaturated fatty acids boost the birth of new neurons
25.11.2009 | Universitat Autonoma de Barcelona

nachricht Johns Hopkins researchers track down protein responsible for chronic rhinosinusitis with polyps
24.11.2009 | Johns Hopkins Medical Institutions

All articles from Health and Medicine >>>

B2B Search

Product / Service
Company / Organisation

Latest News

First black holes may have incubated in giant, starlike cocoons

25.11.2009 | Physics and Astronomy

KfW issues its first ever 7 year Euro-Benchmark

25.11.2009 | Business and Finance

Intelligence inside metal components

25.11.2009 | Information Technology

VideoLinks
More VideoLinks >>>

Event News

Multidisciplinary meeting on Urological Cancers aims to benefit cancer patients

20.11.2009 | Event News

'Golden Age' for clinical psychology in Northern Ireland

20.11.2009 | Event News

New Perspectives in Marine Anti-Fouling Research

11.11.2009 | Event News